Buscador de empleo
Encuentre oportunidades en Novartis y Sandoz a continuación. Para puestos adicionales con Novartis Gene Therapies (anteriormente AveXis), visite GTx Career Search.
Aviso para los solicitantes de ofertas de empleo de EE.UU. Saber más
Showing 2204 results
- Sort by Sort ascending
- Título profesional Sort ascending
- Negocio
- Localización
- Sitio
- Fecha de publicación
| Título profesional Sort ascending | Negocio | Localización | Sitio | Fecha de publicación |
|---|---|---|---|---|
| Senior Principal Scientist/Associate Director, Oncology Drug Discovery Small Molecules Biology Regular, Full time | Pharma Research | Estados Unidos | Cambridge (USA) | Nov 06, 2024 |
| Quality Control Supervisor (Wed-Sat AM) Regular, Full time | Innovative Medicines | Estados Unidos | Morris Plains | Nov 06, 2024 |
| Business Data Migration Expert-Sales Management Regular, Full time | CTS | India +Alternative Locations | Hyderabad (Office) | Nov 06, 2024 |
| Medical Science Liaison Manager, Neuroscience (w/m/d) Gebiet: Hessen, Rheinland-Pfalz und Saarland Regulär (Außendienst), Full time | Innovative Medicines | Alemania | Hessen (Novartis Pharma GmbH) | Nov 06, 2024 |
| Senior Principal Biostatistician Early Development Regular, Full time | Innovative Medicines | Reino Unido | London (The Westworks) | Nov 05, 2024 |
| Responsable Technique, Ingénieur Cyclotron - industrie radiopharmaceutique – Saint Genis Pouilly H/F Regular, Full time | Innovative Medicines | Francia | St-Genis-Prod | Nov 05, 2024 |
| Supervisor, QC Chemistry Regular, Full time | Innovative Medicines | Estados Unidos | Indianapolis | Nov 05, 2024 |
| Supply Chain Management Specialist Regular, Full time | Innovative Medicines | México | INSURGENTES | Nov 05, 2024 |
| Pharmaziepraktikant (w/m/d) in der Patient Safety ab Mai 2025 Early Career (Befristet), Full time | Innovative Medicines | Alemania | Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) | Nov 05, 2024 |
| Global Labelling Manager Regular, Full time | Innovative Medicines | Irlanda | Dublin (NOCC) | Nov 05, 2024 |